LSE • 0RKL • SE0004840718
Generating your data highlights...
N/A USD | # 2314 in GB
6.07k shares | 1.97m USD
31.5m
79.79% | 25.13m
Xvivo Perfusion AB (LSE: 0RKL). Last close SEK 229.00 (as of 2026-10-21); 52-week range SEK 162.40 to SEK 314.00. ORTEX data as of 2026-10-19: short interest is 3.86% of free float, 107.8 days to cover and the average cost to borrow is 1.88%.